标签:
杂谈 |
2007-3-23 13:53:25
Panic disorder remains a common, debilitating condition, accounting
for more than 20% of U.S. hospital emergency room visits. Patients
with the condition are plagued by sudden, uncontrolled symptoms
such as panic, dizziness, and heart palpitations, as well as chest
and abdominal pain.
The small but significant study, involving 49 patients, compared 12
weeks of twice-weekly psychodynamic psychotherapy sessions to
another well-known approach, applied relaxation training
(ART).
"The psychoanalytic strategy was highly effective, achieving nearly
double the level of patient response by the end of treatment as
compared to ART," says Barbara Milrod, MD, the study’s lead
author and associate attending physician at NewYork-Presbyterian
Hospital/Weill Cornell Medical Center. She is also associate
professor of psychiatry at Weill Cornell Medical College.
The findings are significant because the trial, while preliminary,
is among the first to prove clinical efficacy for a psychoanalytic
therapy for any major psychiatric disorder, Milrod says. Her team
published their findings in the American Journal of
Psychiatry.
"Right now, two therapies -- cognitive behavioral psychotherapy
(CBT) and the use of antidepressant or anti-anxiety drugs such as
selective serotonin reuptake inhibitors (SSRIs) -- are the main
forms of treatment for panic disorder in the United States," Milrod
explains.
However, studies suggest that up to half of patients may not
respond to either of these approaches. What is more, many patients,
such as women during pregnancy, prefer not to take a pharmaceutical
therapy, lending urgency to the notion that patients need
effective, non-pharmaceutical options in treating panic
disorder.
That is why there has been a renewed interest in psychodynamic
psychotherapy. "This form of talk therapy has actually been around
since the beginning of the 20th century, and it’s still practiced
by many psychiatrists and psychologists across the U.S. today,"
Milrod says.
Unlike CBT -- which relies on exposure to panic triggers, and a
highly structured set of exercises aimed at easing attacks --
psychodynamic psychotherapy has a different focus. "It’s really
aimed at getting patients to understand the underlying emotional
meaning of their panic, its root psychological causes," Milrod
says. "Once that is achieved, patients can acknowledge previously
unacceptable feelings and ideas, which have led to panic, as they
arise."
Milrod’s team compared the treatment to ART in a 12-week
randomized, controlled clinical trial. "We did not compare
psychodynamic psychotherapy to CBT, but used ART -- a standard
therapy that has often been used in trials aimed at assessing the
effectiveness of other treatment approaches," she says. ART is a
structured, relaxation-focused approach with similarities to
CBT.
The results -- tabulated by Weill Cornell Professor of
Biostatistics in Psychiatry Andrew Leon, PhD -- were
impressive.
The 26 patients in the Panic-Focused Psychodynamic Psychotherapy
(PFPP) group had a greater reduction in their symptoms compared to
the 23 patients in the ART group, the researchers report. In fact,
by the trial’s end, 73% of patients treated with the
psychoanalytic approach met criteria for "response," using standard
definitions of "response" criteria in the field, compared to just
39% of those in the ART cohort.
"It’s important to note that this trial is small, so no definite
conclusions can be drawn at this point as to efficacy. Efficacy is
considered well-established once results such as these are
replicated. However, based on these results, we have already begun
a much larger, two-site clinical trial in collaboration with
researchers at the University of Pennsylvania," Milrod says. "That
trial will compare the effectiveness of psychodynamic psychotherapy
to that of both ART and CBT."
Right now, the important take-home message for patients battling
panic disorder is that psychoanalytic treatment may provide a
much-needed therapeutic option. We know that when it comes to panic
disorder -- and psychological disorders in general -- not everyone
is going to respond to one therapy," Milrod said. "It’s really
important to conduct rigorous trials like these, to let patients
know that they have a real choice."
This study was funded by grants from the National Institute of
Mental Health and a fund in the New York Community Trust
established by DeWitt Wallace.